Fingerprint
Dive into the research topics where Roel Klein Wolterink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
ILC2 in Immunity
Klein Wolterink, R. G. J., 1 Jan 2025, Encyclopedia of Immunobiology. Elsevier, p. V1:288-V1:295 295 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic
-
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
Gong, Y., Germeraad, W. T. V., Zhang, X., Wu, N., Li, B., Janssen, L., He, Z., Gijbels, M. J. J., Wu, B., Gijsbers, B. L. M. G., Olieslagers, T. I., Bos, G. M. J., Zheng, L. & Klein Wolterink, R. G. J., 7 Aug 2024, In: Molecular Therapy. 32, 8, p. 2711-2727 17 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Pellagra: de vergeten groente onder de dermatosen
Logger, J. G. M., Klein Wolterink, R. G. J., de Vries, H. J. C. & Henquet, C. J. M., 1 Jan 2023, In: Nederlands Tijdschrift voor Dermatologie en Venereologie. 33, 1, p. 37-40 4 p.Translated title of the contribution :Pellagra: The forgotten entity among dermatoses Research output: Contribution to journal › Article › Academic
-
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Gong, Y., Wolterink, R. G. J. K., Wang, J. X., Bos, G. M. J. & Germeraad, W. T. V., 1 May 2021, In: Journal of Hematology & Oncology. 14, 1, 35 p., 73.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
Gong, Y., Klein Wolterink, R. G. J., Gulaia, V., Cloosen, S., Ehlers, F. A. I., Wieten, L., Graus, Y. F., Bos, G. M. J. & Germeraad, W. T. V., Jun 2021, In: Cancers. 13, 11, 19 p., 2579.Research output: Contribution to journal › Article › Academic › peer-review
Open Access